DENTSPLY SIRONA (NASDAQ:XRAY) Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) posted its quarterly earnings results on Thursday. The medical instruments supplier reported $0.29 earnings per share for the quarter, missing the consensus estimate of $0.31 by ($0.02), FiscalAI reports. DENTSPLY SIRONA had a negative net margin of 14.99% and a positive return on equity of 20.84%. The business had revenue of $836.00 million for the quarter, compared to analyst estimates of $861.68 million. During the same period in the previous year, the firm posted $0.37 earnings per share. The firm’s quarterly revenue was down 7.5% on a year-over-year basis. DENTSPLY SIRONA updated its FY 2026 guidance to 1.200-1.300 EPS.

Here are the key takeaways from DENTSPLY SIRONA’s conference call:

• DENTSPLY SIRONA lowered its 2026 outlook: sales are now expected to be approximately $3.5 billion, and adjusted EPS $1.20–$1.30, down from prior ranges of $3.5–$3.6 billion and $1.40–$1.50, respectively.
• Q3 revenue fell 7% in constant currency to $836 million, and adjusted EPS declined to $0.29 from $0.42 a year ago. Dental businesses faced lower volumes, planned dealer inventory reductions, and pressure in EMEA.
• Operating cash flow decreased to $32 million from $79 million, primarily due to unfavorable working capital; net debt to EBITDA was 3.4, and management said debt reduction remains a priority.
• Q3 results included a $39 million pre-tax accounting benefit from refining estimates of intercompany profit in inventory transfers; management said it reflects multiple years, is not expected to recur, and is included in the updated EPS outlook.
• Management cited early growth areas, including record Wellspect sales, up 10%, double-digit U.S. growth in MIS implants, and a return to growth in U.S. endodontics. It is expanding sales coverage and clinical education, while cautioning that broader, sustained improvement is still needed.

DENTSPLY SIRONA Stock Performance

Shares of NASDAQ XRAY opened at $10.09 on Friday. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.63 and a quick ratio of 1.07. DENTSPLY SIRONA has a one year low of $8.32 and a one year high of $14.76. The business’s 50-day moving average price is $9.63 and its two-hundred day moving average price is $11.29. The company has a market capitalization of $2.01 billion, a P/E ratio of -3.67, a price-to-earnings-growth ratio of 1.37 and a beta of 0.87.

DENTSPLY SIRONA News Roundup

Here are the key news stories impacting DENTSPLY SIRONA this week:

• Positive Sentiment: RTT News reported that DENTSPLY SIRONA’s third-quarter loss narrowed, offering a favorable note amid weaker operating results. Dentsply Sirona Q3 Loss Narrows
• Negative Sentiment: Quarterly adjusted EPS was $0.29, below the $0.31 consensus and down from $0.37 a year earlier. Revenue of $836 million also missed the $861.7 million estimate and declined 7.5% year over year. DENTSPLY SIRONA Q3 earnings results
• Negative Sentiment: The company guided to 2026 EPS of $1.20–$1.30, versus the $1.47 consensus, and revenue of about $3.5 billion, below the $3.6 billion expected. The lowered outlook is a key source of investor concern. DENTSPLY SIRONA Q3 earnings summary

Analyst Ratings Changes

Several equities analysts have weighed in on the company. Piper Sandler dropped their target price on DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a report on Friday, October 9th. Weiss Ratings reissued a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research report on Friday, October 30th. Leerink Partners decreased their price target on shares of DENTSPLY SIRONA from $14.00 to $10.00 and set a “market perform” rating for the company in a report on Wednesday, October 14th. Barrington Research lowered their price objective on shares of DENTSPLY SIRONA from $15.00 to $13.00 and set an “outperform” rating on the stock in a research report on Monday, October 26th. Finally, Mizuho dropped their price objective on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating on the stock in a research note on Thursday, October 22nd. Three analysts have rated the stock with a Buy rating, eight have given a Hold rating and three have issued a Sell rating to the company. According to data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average target price of $12.58.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA is a global manufacturer of professional dental products and technologies. The company serves dentists, dental specialists, dental laboratories and other oral health professionals with solutions used in preventive, restorative, prosthetic, endodontic and implant dentistry.

Its portfolio includes dental equipment, imaging and treatment systems, CAD/CAM technology, consumable dental materials, orthodontic products, endodontic instruments and solutions, dental implants, prosthetic components and laboratory products.